Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.7 |